ArticleOncotarget2018

Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.

Zhengxiao Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.